Form 13-F position report

BIOXCEL THERAPEUTICS INC

Reported by SBI Securities Co Ltd

BTAI CUSIP 09075P204 Manager CIK 0001851815

Reported 13 shares, down 1 (7.1%) from the prior quarter.

Reported value -5.3%; share count -7.1% vs. the prior quarter.

Reduced
% of reported 13F value < 0.01% This manager · Q2 2026
Shares 13 Quarter-end amount reported
Reported value $18 Fair value at quarter end
Consecutive quarters held 6 Through Q2 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2025-03-31 1728
2025-06-30 1591
2025-09-30 433
2025-12-31 270
2026-03-31 19
2026-06-30 18
2026-09-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

7 quarters
Quarterly reported position history for BIOXCEL THERAPEUTICS INC held by SBI Securities Co Ltd.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Reduced 0 -13 (-100.0%) 0 $0 2026-10-22
Q2 2026 Reduced 13 -1 (-7.1%) < 0.01% $18 2026-07-23
Q1 2026 Reduced 14 -155 (-91.7%) < 0.01% $19 2026-04-28
Q4 2025 Unchanged 169 0 (0.0%) < 0.01% $270 2026-02-03
Q3 2025 Reduced 169 -710 (-80.8%) < 0.01% $433 2025-11-05
Q2 2025 Added 879 +28 (3.3%) < 0.01% $1,591 2025-08-08
Q1 2025 New 851 +851 (0.0%) < 0.01% $1,728 2025-05-02

Who else reported the position

47 managers reported BIOXCEL THERAPEUTICS INC for Q2 2026.

Managers reporting BIOXCEL THERAPEUTICS INC in Q2 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
MILLENNIUM MANAGEMENT LLC Added 2,114,710 +177,950 < 0.01% $2,981,741 4 qtrs
OAKTREE CAPITAL MANAGEMENT LP Added 1,380,248 +1,139,060 0.03% $1,946,150 5 qtrs
VANGUARD CAPITAL MANAGEMENT LLC Added 919,545 +712,206 < 0.01% $1,296,558 2 qtrs
Oaktree Fund Advisors LLC Added 245,585 +202,672 0.6% $346,274 5 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 242,251 +12,083 < 0.01% $341,911 6 qtrs
BlackRock Inc Added 179,433 +95,151 < 0.01% $253,001 6 qtrs
UBS Group AG Added 158,065 +105,277 < 0.01% $222,871 6 qtrs
CITADEL ADVISORS LLC New 149,220 +149,220 < 0.01% $210,400 1 qtr
VANGUARD FIDUCIARY TRUST CO Added 136,937 +52,016 < 0.01% $193,081 2 qtrs
STATE STREET CORPORATION Unchanged 92,118 0 < 0.01% $129,886 4 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2026
Filed
July 23, 2026
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
13
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.